Abstract:Colorectal cancer (CRC) is a heterogeneous group of diseases that are the result of abnormal glucose metabolism alterations with high lactate production by pyruvate to lactate conversion, which remodels acidosis and offers an evolutional advantage for tumor cells, even enhancing their aggressive phenotype. This review summarizes recent findings that involve multiple genes, molecules, and downstream signaling in the dysregulated glycolytic pathway, which can allow a tumor to initiate acid byproducts and to progress, thereby resulting in acidosis commonly found in the tumor microenvironment of CRC. Moreover, the relationship between CRC cells and the tumor acidic microenvironment, especially for regulating lactate production and lactate dehydrogenase A levels, is also discussed, as well as comprehensively defining different aspects of glycolytic pathways that affect cancer cell proliferation, invasion, and migration. Furthermore, this review concentrates on glucose metabolism-mediated transduction factors in CRC, which include acid-sensing ion channels, triosephosphate isomerase and key glycolysis-related enzymes that regulate glycolytic metabolites, coupled with the effect on tumor cell glycolysis as well as signaling pathways. In conclusion, glucose metabolism mediated by glycolytic pathways that are integral to tumor acidosis in CRC is demonstrated. Therefore, selective metabolic inhibitors or agents against these targets in glucose metabolism through glycolytic pathways may be clinically useful to regulate the tumor's acidic microenvironment for CRC treatment and to identify specific targets that regulate tumor acidosis through a cancer patient-personalized approach. Furthermore, strategies for modifying the metabolic processes that effectively inhibit cancer cell growth and tumor progression and activate potent anticancer effects may provide more effective antitumor prospects for CRC therapy.

Advances in glucose metabolism research in colorectal cancer

Advancements in the study of glucose metabolism in relation to tumor progression and treatment

New strategies for targeting glucose metabolism–mediated acidosis for colorectal cancer therapy

Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance

Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment

Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer

CircRNAs: emerging factors for regulating glucose metabolism in colorectal cancer

Structural Aspects of the Glucose and Monocarboxylate Transporters Involved in the Warburg Effect

Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments

Recent Advances in the Glycolytic Processes Linked to Tumor Metastasis

Global research trends and prospects of cellular metabolism in colorectal cancer

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action

Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy

Recent advances microRNAs and metabolic reprogramming in colorectal cancer research

Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies

Tissue metabolomics in diabetic patients with colorectal cancer

Emerging Role of Non-Coding RNAs in Glucose Metabolic Reprogramming and Chemoresistance in Colorectal Cancer

Lactate and lactylation in gastrointestinal cancer: Current progress and perspectives (Review)

Metabolic reprogramming in colorectal cancer: regulatory networks and therapy

Targeting glucose metabolism to develop anticancer treatments and therapeutic patents

Intervention with drug resistance related to metabolism of cancer cells:advances in research